EP 166: Developing targeted therapies for ALS with Eric Green from Trace Neuroscience, Maze Therapeutics, and Stanford University - Trace Neuroscience

Trace Neuroscience

About ALS
Our Focus
Our Team
News & Publications
Investors & Partners
Contact Us

12/19/2024

Share

Home
Privacy Policy
Terms of Service